Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 39,454 |
|
|||||
| News | - | ||||||
| Day High | 2.61 | Low High |
|||||
| Day Low | 2.40 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| VYNE Therapeutics Inc | VYNE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.11 | -4.18% | 2.52 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.60 | 2.40 | 2.61 | 2.52 | 2.63 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 183 | 39,454 | US$ 2.48 | US$ 97,875 | - | 1.67 - 8.81 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:32:14 | 18 | US$ 2.45 | USD |
VYNE Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.54M | 14.10M | - | 424k | -28.45M | -2.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
VYNE Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VYNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.31 | 2.80 | 2.2401 | 2.54 | 105,469 | 0.21 | 9.09% |
| 1 Month | 3.14 | 3.14 | 2.24 | 2.72 | 84,514 | -0.62 | -19.75% |
| 3 Months | 2.14 | 3.17 | 1.90 | 2.53 | 102,443 | 0.38 | 17.76% |
| 6 Months | 3.15 | 4.4808 | 1.67 | 2.69 | 266,517 | -0.63 | -20.00% |
| 1 Year | 5.26 | 8.81 | 1.67 | 3.02 | 147,821 | -2.74 | -52.09% |
| 3 Years | 91.08 | 93.42 | 1.67 | 19.18 | 714,544 | -88.56 | -97.23% |
| 5 Years | 106.56 | 237.60 | 1.67 | 96.01 | 1,248,310 | -104.04 | -97.64% |
VYNE Therapeutics Description
| VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. |
